It seems Riluzole is not so effective as increasing median survival by up to 19 months.
There is an article online entitled: "Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055506/#:~:text=The%20results%20indicate%20that%20riluzole,longer%20than%20participants%20taking%20placebo.
"Riluzole 100 mg daily is reasonably safe and probably prolongs median survival by about two to three months in patients with amyotrophic lateral sclerosis."
Admittedly that was published back in 2012, so have there been more recent studies on the properties of Riluzole?
Amylyx class action Relyvrio, page-12
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $194.1K | 889.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4996 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 114999 | 4 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |